Gene · 2826
Papers2,000
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,000
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mucosal delivery of nanovaccine strategy against COVID-19 and its variants. | Acta Pharm Sin B | 2022 | 36438851 | PubTator, text mining | PubMed |
| Mobilization of Hematopoietic Stem and Progenitor Cells during Dengue Virus Infection. | Int J Mol Sci | 2022 | 36430807 | PubTator, text mining | PubMed |
Allelic Variants of HLA-C Upstream Region, PSORS1C3, MICA, TNFA and Genes Involved in Epidermal Homeostasis and Barrier Function Influence the Clinical Response to Anti-IL-12/IL-23 Treatment of Patients with Psoriasis. | Vaccines (Basel) | 2022 | 36423071 | PubTator, text mining | PubMed |
| A pan-cancer analysis of the oncogenic role of ATP binding cassette subfamily E member 1 (ABCE1) in human tumors: An observational study. | Medicine (Baltimore) | 2022 | 36401432 | PubTator, text mining | PubMed |
| Single-cell analyses reveal novel molecular signatures and pathogenesis in cutaneous T cell lymphoma. | Cell Death Dis | 2022 | 36400759 | PubTator, text mining | PubMed |
| Exploiting the role of T cells in the pathogenesis of Sjögren's syndrome for therapeutic treatment. | Front Immunol | 2022 | 36389806 | PubTator, text mining | PubMed |
| Co-transducing B7H3 CAR-NK cells with the DNR preserves their cytolytic function against GBM in the presence of exogenous TGF-β. | Mol Ther Methods Clin Dev | 2022 | 36381305 | PubTator, text mining | PubMed |
| [Analyze the application rules and effects of "Four Elements, One Peptide, and Two Transplantations" based on bundle treatment in coronavirus disease 2019]. | Zhonghua Wei Zhong Bing Ji Jiu Yi Xue | 2022 | 36377442 | PubTator, text mining | PubMed |
| B cells in human lymphoid structures. | Clin Exp Immunol | 2022 | 36370126 | PubTator, text mining | PubMed |
| Mucosal Immunity and the Gut-Microbiota-Brain-Axis in Neuroimmune Disease. | Int J Mol Sci | 2022 | 36362150 | PubTator, text mining | PubMed |
Ex Vivo Treatment with Allogenic Mesenchymal Stem Cells of a Healthy Donor on Peripheral Blood Mononuclear Cells of Patients with Severe Alopecia Areata: Targeting Dysregulated T Cells and the Acquisition of Immunotolerance. | Int J Mol Sci | 2022 | 36362015 | PubTator, text mining | PubMed |
| Hallmarks of Cancer Expression in Oral Lichen Planus: A Scoping Review of Systematic Reviews and Meta-Analyses. | Int J Mol Sci | 2022 | 36361889 | PubTator, text mining | PubMed |
| Aptamers, a New Therapeutic Opportunity for the Treatment of Multiple Myeloma. | Cancers (Basel) | 2022 | 36358889 | PubTator, text mining | PubMed |
| Targeting the regulation of aberrant protein production pathway in gastrointestinal cancer treatment. | Front Oncol | 2022 | 36338771 | PubTator, text mining | PubMed |
| Prognostic value and immunological role of BAIAP2L2 in liver hepatocellular carcinoma: A pan-cancer analysis. | Front Surg | 2022 | 36338652 | PubTator, text mining | PubMed |
| Identification of adenylate cyclase 2 methylation in bladder cancer with implications for prognosis and immunosuppressive microenvironment. | Front Oncol | 2022 | 36313639 | PubTator, text mining | PubMed |
| Unraveling the surface proteomic profile of multiple myeloma to reveal new immunotherapeutic targets and markers of drug resistance. | Cell Stress | 2022 | 36311892 | PubTator, text mining | PubMed |
| Distinct CD4+ T cell signature in ANA-positive young adult patients. | Front Immunol | 2022 | 36311777 | PubTator, text mining | PubMed |
A comprehensive investigation discovered the novel methyltransferase METTL24 as one presumably prognostic gene for kidney renal clear cell carcinoma potentially modulating tumor immune microenvironment. | Front Immunol | 2022 | 36311770 | PubTator, text mining | PubMed |
| Differential Homing Receptor Profiles of Lymphocytes Induced by Attenuated versus Live Plasmodium falciparum Sporozoites. | Vaccines (Basel) | 2022 | 36298634 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2826/papers?page=17